Founder & Chairman of Diamyd Medical AB that conducts a precision medicine registrational T1D phase-3 study. Share listed on Nasdaq First North in Stockholm
BREAKTHROUGH in Type-1 Diabetes Treatment! Diamyd is on a roll. https://t.co/7V9zBuRFBI via @YouTube
This is a nice story, not written or fact-checked by me, nor is it an investment advise. But we at Diamyd are surely fighting!
@diamyd#diagnode-3 @123T1D
Did you know that Diamyd Medical is conducting precision medicine phase 3 studies in 8 European countries and the US?
@Diamyd. @Diagnode-3 @Diabetes @123T1D